A recent rise in COVID-19 cases in the U.K. may serve as a warning for what’s to come in the U.S. “Generally, what happens in the UK is reflected about a month later in the US. I think this is what I’ve sort of been seeing,” said Dr. Tim Spector, professor of genetic epidemiology at Kings College London. (CNN)

HG Capital and Cinven slammed Advanz Pharma’s ‘quasi-criminal’ £100 million pricing fine. The pharmaceutical firm and its two former private equity owners kicked off an appeal against the Competition and Markets Authority’s July 2021 finding on Tuesday. (Bloomberg)

Mark Cuban said he will pull back from other projects to focus on Cost Plus Drugs. “Part of me wants to quit [Shark Tank],” he says. Cuban said he’s not worried about whether the show will sink or swim. “They’ll survive fine without me.” (Forbes)

Long COVID has forced a reckoning for chronic fatigue syndrome. ME/CFS involves a panoply of debilitating symptoms that affect many organ systems and that get worse with exertion. (The Atlantic)

The Food and Drug Administration said it will review fewer emergency use requests for COVID tests. The agency is revising its COVID-19 test policy in light of the current manufacturing status and the number of cases, adding companies seeking EUA for their COVID tests will now have to apply for the agency’s traditional premarket review process. (Reuters)